Research graph
References from Beyond Fibrosis Stratification: Integrating Behavioural, Metabolic and Policy‐Level Interventions in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Fatty Liver Disease in Australia: A Narrative Review on the Epidemiology, Natural History, Prognostication and Management in People With Metabolic Dysfunction
10.5694/mja2.70195 · 2026 · External reference
Clinical Care Pathway for the Risk Stratification and Management of Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease
10.1053/j.gastro.2026.01.047 · 2026 · External reference
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
10.2337/dci24-0094 · 2025 · External reference
Placebo Rates in Metabolic Dysfunction–Associated Steatohepatitis Clinical Trials: A Systematic Review and Meta‐Analysis
10.1016/j.cgh.2025.09.035 · 2026 · External reference
Continuous Glucose Monitoring as a Behavior Modification Tool
10.2337/cd19-0037 · 2020 · External reference
